CONDITION × MEDICINE
BPC-157, TB-500 and GHK-Cu: reading recovery and anti-ageing claims
Peptide therapeutics include established medicines and compounds under investigation. Being a peptide, or acting in a cell or animal experiment, does not establish clinical benefit for an injected consumer product.
- BPC-157Recovery claims / evidence gap
Proposed biological effects do not establish a clinical recovery benefit.
FDA identifies limited safety information and immunogenicity concerns. Reference ↗
- TB-500 / thymosin beta-4 fragmentRecovery claims / evidence gap
Research terminology does not establish an approved recovery treatment.
Identity, impurities and route-specific evidence need scrutiny. Reference ↗
- Injectable GHK-CuSkin/anti-ageing claims / evidence gap
Topical or mechanistic findings cannot establish injectable benefit.
Human safety data are limited for injected products. Reference ↗